| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |